On September 21st, A-shares collectively rose in early trading, with the Shanghai Composite Index up 0.50%, the Shenzhen Component Index up 0.80%, and the ChiNext Index up 1.29%. The biomedical sector surged, with CRO, innovative drugs, weight-loss drugs, and gene sequencing concept stocks all rising significantly. Storage chip stocks strengthened, with CXMT up 5%.

Hong Kong stocks saw mixed performance, with the Hang Seng Index up 0.51%. The Hang Seng Tech Index rose initially before pulling back and turning negative, while the Hang Seng Biotech Index surged nearly 5%.

Most domestic commodity futures rose, but crude oil fell sharply by 6%, and pulp gained 3%.